Predictions of mortality from pleural mesothelioma in Italy: A model based on asbestos consumption figures supports results from age-period-cohort models

International Journal of Cancer

Volumn 115, Issue 1, 2005, Pages 142-147

  Marinaccio, Alessandro ^a   Montanaro, Fabio ^b   Mastrantonio, Marina ^c   Uccelli, Raffaella ^c   Altavista, Pierluigi ^c   Nesti, Massimo ^a   Costantini, Adele Seniori ^d   Gorini, Giuseppe ^d  

^a Natl Inst for Occup Safety/Prev   (Italy)

^b INSTITUTE OF PATHOLOGY   (Switzerland)

^c ENEA   (Italy)

^d CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

Asbestos consumption; Mesothelioma; National data; Pleural cancer

Indexed keywords

ASBESTOS; CROCIDOLITE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; COHORT ANALYSIS; DIAGNOSTIC ERROR; ENVIRONMENTAL EXPOSURE; EUROPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; PLEURA CANCER; PLEURA MESOTHELIOMA; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASBESTOS; COHORT STUDIES; HUMANS; ITALY; MALE; MESOTHELIOMA; MIDDLE AGED; MODELS, STATISTICAL; OCCUPATIONAL EXPOSURE; PLEURAL NEOPLASMS; TIME FACTORS;

EID: 17644387735     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20820     Document Type: Article

References (39)

1. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Resp J 1996;9:1932-42.
2. Boffetta P, Burdorf A, Goldberg M, Merler E, Siemiatycki J. Towards the coordination of European research on the carcinogenic effects of asbestos. Scand J Work Environ Health 1998;24:312-7.
3. Spirtas R, Connelly RR, Tucker MA. Survival patterns for malignant mesothelioma: the SEER experience. Int J Cancer 1988;41:525-30.
4. Magnani C, Viscomi S, Dalmasso P, Ivaldi C, Mirabelli D, Terracini B. Survival after pleural malignant mesothelioma: a population-based study in Italy. Tumori 2002;88:266-9.
5. Marinaccio A, Nesti M, Regional Operational Centers. Analysis of survival of mesothelioma cases in Italian register (ReNaM). Eur J Cancer 2003;39:1290-5.
6. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-72.
7. Gorini G, Merler E, Chellini E, Crocetti E, Costantini AS. Is the ratio of pleural mesothelioma mortality to pleural cancer mortality approximately unity for Italy? considerations from the oldest regional mesothelioma register in Italy. Br J Cancer 2002;86:1970-1.
8. Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, ENCR working group. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 2003;14:791-803.
9. McDonald JC. Health implications of environmental exposure to asbestos. Environ Health Perspect 1985;62:319-28.
10. Selikoff IJ, Hammond EC, Seidmann H. Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 1980;46:2736-40.
11. Segura O, Burdorf A, Looman C. Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 2003;60:50-5.
12. Hemminki K, Li X. Mesothelioma incidence seems to have leveled off in Sweden. Int J Cancer 2003;103:145-6.
13. Health and Safety Executive. Mesothelioma mortality in Great Britain: estimating the future burden. Health and Safety Executive, 2003.
14. Kjaergaard J, Anderson M. Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scand J Work Environ Health 2000;26:112-7.
15. Ulvestad B, Kjaerheim K, Moller B, Andersen A. Incidence trends of mesothelioma in Norway, 1965-1999. Int J Cancer 2003;107:94-8.
16. Järvholm B, Englund A, Albin M. Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med 1999;56:110-3.
17. Karjalainen A, Pukkala E, Mattson K, Tammilehto L, Vainio H. Trends in mesothelioma incidence and occupational mesotheliomas in Finland in 1960-1995. Scand J Work Environ Health 1997;23:266-70.
18. Gilg Soint Ilg A, Bignon J, Valleron AJ. Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med 1998;55:760-5.
19. Price B, Ware A. Mesothelioma trends in the United States: an update based on surveillance, epidemiology and end results program data for 1973 through 2003. Am J Epidemiol 2004;159:107-12.
20. Leigh J, Davidson P, Leigh H, Berry D. Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med 2002;41:188-201.
21. Zanetti R, Crosignani P, Rosso S, eds. Il canero in Italia: i dati di incidenza dei registri tumori. Rome: Pensiero Scientifico Editore, 1997.
22. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer incidence in five continents, vol. 7. Lyon: IARC, 1997.
23. Italian Institute of Statistics. Previsioni della popolazione: anni 2001-2051. Italian Institute of Statistics. Rome, Italy; 1991-92.
24. Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet 1995;345:535-9.
25. Clayton D, Schiffler E. Models for temporal variation in cancer rates: I, age-period and age-cohort models. Stat Med 1987;6:449-67.
26. Clayton D, Schiffler E. Models for temporal variation in cancer rates: II, age-period-cohort models. Stat Med 1987;6:469-81.
27. McCullagh P, Nelder JA. Generalized linear models. London: Chapman and Hall, 1989.
28. Italian Institute of Statistics. Statistiche del commercio con l'estero e statistiche della produzione industriale: vari anni. Italian Institute of Statistics. Rome, Italy, 2002.
29. Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S. Future trends in mortality of French men from mesothelioma. Occup Environ Med 2000;57:488-94.
30. Iwatsubo Y, Matrat M, Michel E, Boutin C, Galateau-Salle F, Jougla E, Bignon J, Pairon JC, Brochard P. Estimation of the incidence of pleural mesothelioma according to death certificates in France. Am J Ind Med. 2002;42:188-99.
31. Bruno C, Comba P, Maiozzi P, Vetrugno T. Accuracy of death certification of pleural mesothelioma in Italy. Eur J Epidemiol 1996;12:421-3.
32. Nesti M, Marinaccio A, Chellim E. Regional Operational Centers. Malignant mesothelioma in Italy, 1997. Am J Ind Med 2004;45:55-62.
33. Neumann V, Gunther S, Muller KM, Fischer M. Malignant mesothelioma: German mesothelioma register 1987-1999. Int Arch Occup Environ Health 2001;74:383-95.
34. Desoubeaux N, Bouvier V, Gervais R, Galateau-Salle F, Thibon P, Leplumey T, Herbert C, Lecherbonnier Y, Daviet JP, Letourneux M. Mésothé liomes malins en Basse-Normandie: analyse descriptive, facteurs pronostiques et survie-une étude de population. Rev Epidemiol Sante Publ 2001;49:523-9.
35. Yeung P, Rogers A, Johnson A. Distribution of mesothelioma cases in different occupational groups and industries in Australia, 1979-1995. Appl Occup Environ Hyg 1999;14:759-67.
36. Bianchi C, Giarelli L, Grandi G, Brollo A, Ramani L, Zuch C. Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 1997;6:162-6.
37. Lanphear B, Buncher C. Latent period for malignant mesothelioma of occupational origin. Occup Med 1992;34:718-21.
38. Takahashi K, Huuskonen MS, Tossavainen A, Higashi T, Okubo T, Rantanen J. Ecological relationship between mesothelioma incidence/mortality and asbestos consumption in ten western countries and Japan. J Occup Health 1999;41:8-11.
39. Tossavainen A. National mesothelioma incidence and past use of asbestos. Monaldi Arch Chest Dis 2003;59:146-9.